Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, April 21, 2016

Remote Italian village could harbor secrets of healthy aging

Likely to be the amount of walking they do every day.

Remote Italian village could harbor secrets of healthy aging

The average life expectancy in the United States is approximately 78 years old. Americans live longer, with better diets and improved health care, than ever before, but only 0.02 percent will hit the century mark.
To understand how people can live longer throughout the world, researchers at University of California, San Diego School of Medicine have teamed up with colleagues at University of Rome La Sapienza to study a group of 300 citizens, all over 100 years old, living in a remote Italian village nestled between the ocean and mountains on the country’s coast.
Acciaroli, Italy
Researchers are studying residents of a remote Italian village to better understand aging and longevity. Photo courtesy of La Citta di Salerno
“We are the first group of researchers to be given permission to study this population in Acciaroli, Italy,” said Alan Maisel, MD, lead UC San Diego School of Medicine investigator and professor of medicine in the Division of Cardiovascular Medicine.
The Acciaroli study group is known to have very low rates of heart disease and Alzheimer’s. It favors a Mediterranean diet markedly infused with the herb rosemary. Due to the location of the village, Maisel said locals also walk long distances and hike through the mountains as part of their daily activity.
“The goal of this long-term study is to find out why this group of 300 is living so long by conducting a full genetic analysis and examining lifestyle behaviors, like diet and exercise,” said Maisel. “The results from studying the longevity of this group could be applied to our practice at UC San Diego and to patients all over the world.”
Maisel and his research team will work with their Italian counterparts to collect blood samples and distribute questionnaires to the group over the next six months.
The study will also involve tests to look at metabolomics, biomes, cognitive dysfunction and protein biomarkers for risk of heart disease, Alzheimer’s, kidney disease and cancer.
“This project will not only help to unlock some of the secrets of healthy aging, but will build closer ties with researchers across the globe, which will lead to more science and improved clinical care in our aging population,” said Salvatore DiSomma, MD, lead Italian investigator and professor of emergency medicine at University of Rome La Sapienza.
Co-authors include Nicholas Schork, Robert Rissman, Chris Benner, Tatianna Kisseleva, William Kremen, Rob Knight, Dillip Jeste, Lori Daniels, Carol Franz, and Mohit Jain, all with UC San Diego.
The study is supported, in part, from European grants.

No comments:

Post a Comment